Nanobiotix SA Sponsored ADR NBTX 深 滬
等待開盤 03-26 09:30:00 美东时间
30.63
+1.360
+4.65%
華盛通- 最 高33.10
- 今 開30.95
- 成交量 10.33万股
- 最 低 30.52
- 昨 收 29.27
- 總市值 14.82亿
- 52周最高 41.8899
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 2.9855
- 委 比 -99.75%
- 總股本 4838.80万
- 歷史最高 41.8899
- 量 比 1.48
- 振 幅 8.81%
- 歷史最低 1.75
- 每 手 1
- 風險率 9.70%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Nanobiotix Issues Statement Regarding Recent Media Speculation Concerning Intentions For A Potential Public Takeover; Says There Is No Such Intention To Acquire Control Of The Company, And No Process Or Assessment Is Being Conducted Toward That End
NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, today issued the following
03-25 22:16
El Pollo Loco Posts Upbeat Q4 Results, Joins Kyivstar Group, American Public Education And Other Big Stocks Moving Higher On Friday
U.S. stocks higher as Dow Jones gains 300 points; El Pollo LoCo Holdings jumps 17.6% on better-than-expected Q4 results and Benchmark upgrade.
03-13 21:59
美股大行评级 | 遭多家大行下调目标价！亚马逊、Affirm、Roblox、汤森路透、Doximity、OneMain、Atlassian、Peloton等等
今日重点评级关注：HC Wainwright & Co.：维持NovaBridge Biosciences"买入"评级，目标价从7美元升至9美元；Truist Securities：维持Reddit"买入"评级，目标价从270美元升至275美元
02-09 14:37
Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $26
Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the price target from $8 to $26.
02-06 22:40
Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were mostly lower this morning, with the S&P 500 futures...
2025-11-11 21:29
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Alphatec Holdings (NASDAQ:ATEC) shares rose 21.7% to $19.88 during Fri...
2025-10-31 20:10
Nanobiotix And HealthCare Royalty Ink 71M Non-Dilutive Financing Agreement To Support JNJ-1900 (NBTXR3) Development And Long-Term Growth
$71 million in funding would extend Nanobiotix cash visibility into early 2028Transaction enables Nanobiotix development beyond key milestones in head and neck cancer and lung cancerFinancing establishes financial
2025-10-31 15:18
Wayfair, Qorvo, Celestica, United Parcel Service, Regeneron Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on ...
2025-10-28 22:14
NANOBIOTIX Announces Updates to JNJ-1900 (NBTXR3) Clinical Program Following Transfer of Ongoing Phase 3 Head and Neck Cancer Trial Sponsorship and Operational Control
Nanobiotix announced the completion of transferring sponsorship and operational control of the NANORAY-312 clinical trial for JNJ-1900 (NBTXR3) to Johnson & Johnson. Interim data analysis is expected in 1H2027 after recruitment and requisite events. Nanobiotix will continue to provide updates on its sponsored studies and collaborations. JNJ-1900, a novel oncology product, is activated by radiotherapy and has shown potential in treating solid tumo...
2025-10-24 06:00
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining aroun...
2025-10-20 20:10
